Udo Vetter - Gerresheimer AG Insider

GRRMF -- USA Stock  

USD 82.05  0.00  0.00%

Member of the Supervisory Board

Mr. Udo J. Vetter was Member of the Supervisory Board at Gerresheimer AG since May 14, 2007. He is a Pharmacist und General Partner of UVCap GmbH Co. KG, Ravensburg. He is also Chairman of the Supervisory Board at EDT AG, ItM AG, Vetter Pharma Fertigungs GmbH Co. KG, Paschal Werk G. Maier GmbH, Medisynthana GmbH, Atoll GmbH and SeaLionPharman Pte. Ltd. Furthermore, he is Member of the Supervisory Board at HSM GmbH Co. KG, K M Praezisionstechnik GmbH and Gland Pharma Pte. Ltd., among others. He was Managing Director of Vetter Injekt System GmbH Co. KG between 1989 and 2003. He was also Member of the Executive Committee of the Vetter Group between 1999 and 2003. In 2004 he was appointed as Managing Partner of the UVCap GmbH Co. KG private equity company. Since 2006 he has also been Managing Partner of the real estate holding MMC GmbH Co. KG. In 2007 he joined the Advisory Board of Vetter Pharma Fertigung GmbH Co. KG and since 2008 he was Advisory Board Chairman. In 2007 he was appointed to the Vetter Executive Committee. He graduated from University of Washington with BS in Pharmacy. He is Member of the Nomination Committee at the Company.
Age: 63  Executive Since 2007      
49 211 6181 00  http://www.gerresheimer.com

Management Efficiency

The company has return on total asset (ROA) of 4.24 % which means that it generated profit of $4.24 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 17.22 % meaning that it generated $17.22 on every $100 dollars invested by stockholders.
The company has accumulated 1.26 B in total debt with debt to equity ratio (D/E) of 124.8 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Gerresheimer AG has Current Ratio of 1.09 suggesting that it is not liquid enough and may have problems to pay out its financial obligations in time and when they become due.

Similar Executives

Found 3 records


Soumendra DasSJVN Limited
Timothy WrightTeva Pharmaceutical Industries
David StarkTeva Pharmaceutical Industries

Entity Summary

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. The company was founded in 1864 and is headquartered in Dsseldorf, Germany. Gerresheimer AG operates under Medical Instruments Supplies classification in USA and traded on OTC Market. It employs 9773 people.Gerresheimer AG (GRRMF) is traded on OTC Market in USA. It is located in Klaus-Bungert-Strasse 4 and employs 9,773 people.

Gerresheimer AG Leadership Team

Heike Arndt, Executive
Peter Noe, Executive, Ph.D
Katja Moegel, Executive
Francesco Grioli, Chairman
Axel Herberg, Executive
Anke Linnarzt, Director
Gerhard Schulze, Chairman
Andreas Schuette, Executive
Franz Hartinger, Executive
Eugen Heinz, Executive
Seppel Kraus, Executive
Lukas Burkhardt, Executive, Ph.D
Andrea Abt, Executive
Severine Camp, Director
Markus Rocholz, Executive
Christian Fischer, CEO
Lydia Armer, Executive
Karin Dorrepaal, Executive, Ph.D
Uwe Roehrhoff, Executive
Theodor Stuth, Executive
Rainer Beaujean, CFO
Udo Vetter, Executive
Sonja Apel, Director
Paul Schilling, Executive
Katja Schnitzler, Executive

Stock Performance Indicators

Did you try this?

Run Money Managers Now

Money Managers

Screen money managers from public funds and ETFs managed around the world
All  Next Launch Money Managers

Generate Optimal Portfolios

Align your risk and return expectations
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please also check Risk vs Return Analysis. Please also try Focused Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.